Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A Review

Oper Neurosurg (Hagerstown). 2023 May 1;24(5):469-475. doi: 10.1227/ons.0000000000000656. Epub 2023 Mar 10.


Middle meningeal artery embolization (MMAE) for chronic subdural hematomas (cSDHs) has evolved as a potential treatment alternative for these lesions. The indications for using this treatment modality and the pathophysiology of cSDHs are an area of considerable interest. A retrospective review was performed including all major papers addressing this topic. Although considered a relatively new treatment option, MMAE for cSDHs is gaining widespread popularity. There are many questions that need to be addressed regarding its indications, some of which are the subject of ongoing clinical trials. The efficacy of this treatment modality in carefully selected patients has also provided new insights into the potential pathophysiology of cSDHs. This concise review will focus on the current evidence supporting the use of embolization in the treatment of this disease and highlight unanswered relevant clinical questions regarding MMAE indications and technique.

Publication types

  • Review

MeSH terms

  • Embolization, Therapeutic* / methods
  • Hematoma, Subdural, Chronic* / therapy
  • Humans
  • Meningeal Arteries
  • Retrospective Studies